Latent Style-based Quantum Wasserstein GAN for Drug Design

ArXi:2603.22399v1 Announce Type: cross The development of new drugs is a tedious, time-consuming, and expensive process, for which the average costs are estimated to be up to around $2.5B. The first step in this long process is the design of the new drug, for which de novo drug design, assisted by artificial intelligence, has blossomed in recent years and revolutionized the field. In particular, generative artificial intelligence has delivered promising results in drug discovery and development, reducing costs and the time to solution.